SEARCH

SEARCH BY CITATION

References

  • Brent, D.A., Kolko, D.J., Birmaher, B., Baugher, M., Bridge, J., Roth, C., & Holder, D. (1998). Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 906914.
  • American Psychiatric Press. (1994). Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV). Washington, DC: American Psychiatric Press.
  • Emslie, G.J., Heiligenstein, J.H., Wagner, K.D., Hoog, S.L., Ernest, D.E., Brown, E., Neilsson, M., & Jacobson, J.G. (2002a). Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 12051215.
  • Emslie, G.J., Findling, R.L., Rynn, M.A., Marcus, R.N., Fernandes, L.A., D'Amico, M.F., & Hardy, S.A. (2002b). Efficacy and safety of nefazodone in the treatment of adolescents with major depressive disorder. Journal of Child and Adolescent Psychopharmacology, 12, 299.
  • Emslie, G.J., Findling, R.L., Yeung, P.P., Kunz, N.R., Li, Y., & Durn, B.L. (2004a). Efficacy and safety of venlafaxine ER in children and adolescents with major depressive disorder. Presented at the American Psychiatric Association, New York, May.
  • Emslie, G.J., Wagner, K.D., Kutcher, S.P., Krulewicz, S., Carpenter, D.J., & Lipschitz, A. (2004b). Paroxetine treatment in children and adolescents with major depression disorder. Presented at the 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington, DC.
  • Emslie, G.J., Rush, A.J., Weinberg, W.A., Kowatch, R.A., Hughes, C.W., Carmody, T., & Rintelmann, J.W. (1997). Double-blind placebo controlled study of fluoxetine in depressed children and adolescents. Archives of General Psychiatry, 54, 10311037.
  • Emslie, G.J., Weinberg, W.A., Rush, A.J., Adams, R.M., & Rintelmann, J.W. (1990). Depressive symptoms by self–report in adolescence. Journal of Child Neurology, 3, 114121.
  • Greenhill, L., Vitiello, B., Riddle, M., et al. (2003). Review of safety assessment methods used in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 627633.
  • Harrington, R., Fudge, H., Rutter, M., Pickles, A., & Hill, J. (1990). Adult outcomes of childhood and adolescent depression. I: Psychiatric status. Archives of General Psychiatry, 47, 465473.
  • Hazell, P., O'Connell, D., Heathcote, D., & Henry, D. (2002). Tricyclic drugs for depression in children and adolescents. Cochrane Database Systems Review, 2, CD002317.
  • Jaffee, S.R., Moffitt, R.E., Caspi, A., Fombonne, E., Poulton, R., & Martin, J. (2002). Differences in early childhood risk factors for juvenile-onset and adult-onset depression. Archives of General Psychiatry, 59, 215222.
  • Jensen, P., Bhatara, V., Vitiello, B., Hoagwood, K., Feil, M., & Burke, L.B. (1999). Psychoactive medication prescribing practices for US children: Gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 557565.
  • Jensen, P.S., Ryan, N.D., & Prien, R. (1992). Psychopharmacology of child and adolescent major depression. Journal of Child Psychopharmacology, 2, 3145.
  • Keller, M.B., Ryan, N.D., Strober, M., Klein, R.G., Kutcher, S.P., Birmaher, B., Hagino, W.R., Koplewicz, H., Carlson, G.A., Clarke, G.N., Emslie, G.J., Feinberg, D., Geller, B., Kusumakar, V., Paptheodorou, G., Sack, W.H., Sweeney, M., Wagner, K.D., Weller, E.B., Winters, N.C., Oakes, R., & McCafferty, J.P. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 762772.
  • Mandoki, M.W., Tapia, M.R., Tapia, M.A., Sumner, G.S., & Parker, J.L. (1997). Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacological Bulletin, 33, 149154.
  • March, J., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J., Burns, B., Domino, M., McNulty, S., Vitiello, B., & Severe, J. (2004). Treatment for Adolescents with Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association, 292, 807820.
  • Martin, A., Young, C., Leckman, J.F., Mukonoweshuro, C., Rosentheck, R., & Leslie, D. (2004). Age effects on antidepressant-induced manic conversion. Archives of Pediatric Adolescent Medicine, 158, 773780.
  • MMWR. (2002). Youth risk behavior surveillance. CDC, 51, ss4.
  • National Center for Health Statistics. (2001). Death rates for 72 selected causes, by 5-year groups, race and sex: United States, 1979–1997. Hyattsville, MD: National Center for Health Statistics, 485490.
  • Olfson, M., Shaffer, D., Marcus, S.C., & Greenberg, T. (2003). Relationship between antidepressant medication treatment and suicide in adolescents. Archives of General Psychiatry, 60, 978982.
  • Poznanski, E.O., Grossman, J.A., Buchsbaum, Y., Banegas, M., Freeman, L., & Gibbons, R. (1984). Preliminary studies of the reliability and validity of the children's depression rating scale. Journal of the American Academy of Child and Adolescent Psychiatry, 23, 191197.
  • Rabkin, J.G., & Markowitz, J.S. (1986). Side effect assessment with SAFTEE. Psychopharmacological Bulletin, 22, 389396.
  • Rintelmann, J.W., Emslie, G.J., Rush, A.J., Varghese, T., Gullion, C.M., Kowatch, R.A. & Hughes, C.W. (1996). The effects of extended evaluation on depressive symptoms in children and adolescents. Journal of Affective Disorders, 41, 149156.
  • Shaffer, D., & Waslick, B. (2002). The many faces of depression. Washington, DC: American Psychiatric Publishing.
  • Simeon, J.G., Dinicola, V.F., Ferguson, B.H., & Copping, W. (1990). Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 14, 791795.
  • Wagner, K.D., Ambrosini, P.J., Rynn, M., et al. (2003). Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. Journal of the American Medical Association, 290, 10331041.
  • Wagner, K.D., Robb, A.S., Findling, R.L., Jin, J., Gutierrez, M.M., & Heydorn, W.E. (2004). A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. American Journal of Psychiatry, 161, 10791083.
  • Weissman, M.M., Wolk, S., Goldstein, R.B., Moreau, D., Adams, P., Greenwald, S., Klier, C.M., Ryan, N.D., Dahl, R.E., & Wickramaratne, P. (1999). Depressed adolescents grown up. Journal of the American Medical Association, 281, 17071713.
  • FDA website: http://www.fda.gov/cder/drug/antidepressants/
  • MHRA website: http://www.mhra.gov.uk/news/2003.htm
  • GSK website: GlaxoSmith Kline website: http://www.gsk.com/media/paroxetine.htm